IonQ Shares Fall 6.13% to $23.32 After Two Straight Sessions of Losses
Key Facts
IonQ shares closed at $23.32 on November 18, 2026, down 6.13% from the previous session, according to Investing.com data, extending their decline for a second straight session. The stock had fallen 6.09% on November 17 to $24.84, after dropping 8.41% on November 16 to $26.45. The downward trend coincided with a regulatory filing that allows shareholders to sell existing shares, but does not mean new shares are being issued as part of the registered offering. IonQ said in the resale prospectus that it would receive no proceeds from the sales. This puts the share move in the context of an increase in shares available for sale, while distinguishing the resale of shares held by shareholders from new financing received by the company.
The prospectus covers the resale of up to 34,580,646 common shares by selling shareholders, according to the company’s filing with the U.S. Securities and Exchange Commission. There were 462,881,896 shares outstanding as of November 10, 2026, the figure cited in the filing before the resale offering. The company explicitly stated that the number of shares outstanding would not change as a result of the offering. The shares covered by the prospectus are therefore existing shares being resold by their holders, and do not in themselves represent an increase in the number of shares outstanding when the sale is completed. The registered shares are tied to the acquisition agreement for Elisity dated October 9, 2026, according to the prospectus. This link explains the origin of the shares that may be offered for sale, while the proceeds from any sale go to the selling shareholders, not the company.
This filing differs from the October offering, which raised financing for IonQ. The company announced an offering of 20,500,000 common shares and 29,500,000 pre-funded warrants to purchase shares, at $40 per share or pre-funded warrant. The offering also included seven-year warrants to purchase an additional 100,000,000 shares at an exercise price of $69.46 per share, according to the investor relations announcement. The company closed the $2.0 billion share offering on October 16. It said cash, cash equivalents and investments totaled $1.7 billion as of September 30, and would have totaled $3.7 billion on a pro forma basis after accounting for the offering. The comparison highlights the different purpose of the two transactions: the October offering added financing for the company, while the November prospectus allows the resale of existing shares and does not direct sale proceeds to IonQ’s treasury.
The filing follows IonQ’s announcement of strong third-quarter results and an increase to its annual outlook. The company reported revenue of $173.8 million in the third quarter of 2026, up 336% year over year, according to its statement. It raised its fiscal 2026 revenue outlook to a range of $505 million to $515 million and said it expects quantum computing revenue to grow 110% year over year. It also reported that remaining performance obligations more than doubled to $1.2 billion. The company attributed quarterly revenue to rising demand and integrated manufacturing capabilities through SkyWater. These figures present the growth side of the financial picture, alongside the share and financing disclosures that are central to investor attention during this period.
The Elisity agreement includes incentives tied to revenue at the acquired company that could total $150 million, payable in shares if the specified targets are met. The maximum incentive is $75 million for each measurement period, and the share price is calculated at $35.1609 per share. The first measurement period runs through July 31, 2027, and the second through January 31, 2028, according to the agreement terms set out in the prospectus. IonQ had announced that its acquisition of Elisity was an all-stock deal valued at up to $1.3 billion. The number of shares in the deal is determined at closing based on the volume-weighted average price over 20 trading sessions, subject to a floor of $33.07 and a cap of $49.61 per share. The deal arrangements therefore include shares tied to completion and future incentives contingent on performance and revenue.
Operating results show widening losses alongside revenue growth. Operating losses totaled $1,041.8 million during the nine months ended September 30, 2026, compared with $405.1 million in the same period of 2025, according to the quarterly report filed with the SEC. The company said it expects to incur significant losses for the foreseeable future. This disclosure adds financial context to the October offering, which raised cash and investments to $3.7 billion on a pro forma basis, and to the revenue outlook the company announced for the year. IonQ is scheduled to participate virtually in the Northland 2026 Growth Conference on December 16, according to its announcement. The conference is the company’s next announced event among those cited in its filing.